Cargando…
The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa
BACKGROUND: The lack of validated outcome measures for epidermolysis bullosa (EB) presents major barriers to evaluating disease severity and comparing the efficacy of therapies. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) was recently introduced as a valid and reliable ins...
Autores principales: | Jain, S.V., Harris, A.G., Su, J.C., Orchard, D., Warren, L.J., McManus, H., Murrell, D.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412907/ https://www.ncbi.nlm.nih.gov/pubmed/27580431 http://dx.doi.org/10.1111/jdv.13953 |
Ejemplares similares
-
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
por: Rogers, Clare L., et al.
Publicado: (2021) -
Inherited epidermolysis bullosa
por: Fine, Jo-David
Publicado: (2010) -
Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018) -
Epidermolysis bullosa acquisita()
por: Miyamoto, Denise, et al.
Publicado: (2022) -
Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies
por: Ho, Genevieve, et al.
Publicado: (2022)